Global Human Chorionic Gonadotropin Market Report 2024

Human Chorionic Gonadotropin Global Market Report 2025 – By Technology (Natural Source Extraction, Recombinant Technology), By Therapeutic Area (Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Fertility Clinics, Research Institutions, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Human Chorionic Gonadotropin Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Human Chorionic Gonadotropin Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Human Chorionic Gonadotropin Market Definition

Human chorionic gonadotropin (hCG) is a hormone produced during pregnancy. It is produced by the placenta shortly after the embryo implants in the uterus. hCG plays a critical role in maintaining pregnancy by stimulating the corpus luteum (a structure in the ovary) to produce progesterone, which supports the uterine lining and prevents IT from breaking down.

The main technologies of human chorionic gonadotropin are natural source extraction and recombinant technology. Recombinant technology refers to a laboratory method that involves combining DNA fragments from different organisms to create new genetic combinations. The therapeutic areas are Female Infertility Treatment, oligospermic treatment, male hypogonadism, and others, and are distributed through several channels including hospital pharmacies, retail pharmacies, and online pharmacies. The various end users involved are fertility clinics, research institutions, and others.

Human Chorionic Gonadotropin Market Segmentation

The human chorionic gonadotropin market covered in this report is segmented –

1) By Technology: Natural Source Extraction, Recombinant Technology

2) By Therapeutic Area: Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Fertility Clinics, Research Institutions, Other End Users

Subsegments:

1) By Natural Source Extraction: Extraction From Pregnant Women's Urine, Extraction From Animal Sources

2) By Recombinant Technology: Recombinant Hcg, Recombinant Hcg For Therapeutic Use, Recombinant Hcg For Diagnostic Applications

Human Chorionic Gonadotropin Market Size and growth rate 2025 to 2029: Graph

Human Chorionic Gonadotropin Market Size 2025 And Growth Rate

The human chorionic gonadotropin market size has grown strongly in recent years. It will grow from $0.95 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the rise in the prevalence of hypogonadism in the geriatric population, increase in awareness toward HCG among healthcare professionals and patients, rise in popularity of fertility tourism, increase in the geriatric population, and increase in affordability and improvement in healthcare facilities.

Human Chorionic Gonadotropin Market Growth Forecast

The human chorionic gonadotropin market size is expected to see strong growth in the next few years. It will grow to $1.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to the increasing incidence of infertility, surging prevalence of polycystic ovary syndrome, increasing female infertility, and rising usage of HCG in veterinary medicine. Major trends in the forecast period include advancements in pregnancy detection, innovative drug formulations, technological integration, focus on research and development, and product innovation.

Human Chorionic Gonadotropin Market Driver: Rising Infertility Rates to Fuel Growth In Human Chorionic Gonadotropin Market

An increasing rate of infertility is expected to drive the growth of the human chorionic gonadotropin market going forward. Infertility refers to the inability to conceive after at least one year of consistent, unprotected intercourse. The infertility rate is increasing with the growing prevalence of individuals and couples experiencing difficulties in conceiving due to factors such as delayed childbearing, lifestyle changes, environmental exposures, and medical conditions. Human chorionic gonadotropin (hCG) is used in infertility treatments to stimulate ovulation in women and support testosterone production in men, facilitating the release of eggs and improving fertility outcomes. For instance, in April 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, infertility affected around 17.5% of the adult population, or roughly one in every six people worldwide, highlighting the critical need to improve access to inexpensive, high-quality fertility care for individuals in need. Therefore, an increasing rate of infertility is driving the growth of the human chorionic gonadotropin market.

Global Human Chorionic Gonadotropin Market Major Players

Major companies operating in the human chorionic gonadotropin market are Pfizer Inc., Merck & Co Inc., Novartis AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, Janssen Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Menarini Group, Cipla Limited, Hikma Pharmaceuticals plc, Ferring Pharmaceuticals Inc., Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Lupin Limited, Shenzhen Hepalink Pharmaceutical Group Co. Ltd., Scripps Laboratories Inc., Aspen Pharmacare Holdings Limited, Corona Remedies Pvt Ltd., Sanzyme Private Limited, Biocare Medical LLC, Lee BioSolutions Inc., MyBioSource Inc.

Global Human Chorionic Gonadotropin Market Trend: hCG Test Kits Enhance Early Pregnancy Detection

Major companies operating in the human chorionic gonadotropin market are focusing on developing innovative products, such as pregnancy detection kits, to improve diagnostic accuracy, enhance patient outcomes, and expand their market reach. Pregnancy detection kits are tools designed to confirm whether an individual is pregnant by detecting the presence of human chorionic gonadotropin (hCG) in their body. For instance, in June 2022, Proov, a US-based medical equipment manufacturing company, launched new hCG tests specifically designed for early pregnancy detection, enabling women to verify pregnancy up to six days before their expected period. These tests function by identifying the presence of human chorionic gonadotropin (hCG) in the urine. It offers high accuracy, with a reliability rate exceeding 99. This innovation seeks to provide women with a dependable and accessible method to monitor their pregnancy status earlier than traditional tests, empowering them to make informed decisions regarding their reproductive health.

Human Chorionic Gonadotropin Market Merger And Acquisition: Lupin Acquires Five Established Brands from Menarini to Enhance Therapeutic Portfolio

In September 2023, Lupin Limited, an India-based pharmaceutical company, acquired the five brands from Menarini for an undisclosed sum. With this acquisition, Lupin aims to expand its portfolio and strengthen its presence in key therapeutic areas by integrating five established brands from Menarini. Menarini Group is an Italy-based pharmaceutical and diagnostics company that provides services related to human chorionic gonadotropin (hCG).

Regional Outlook For The Global Human Chorionic Gonadotropin Market

North America was the largest region in the human chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the human chorionic gonadotropin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Human Chorionic Gonadotropin Market?

The human chorionic gonadotropin market includes revenues earned by entities by providing services such as fertility treatments, hormone level monitoring, assisted reproductive technologies (ART), and pregnancy testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Human Chorionic Gonadotropin Industry?

The human chorionic gonadotropin market research report is one of a series of new reports from The Business Research Company that provides human chorionic gonadotropin market statistics, including human chorionic gonadotropin industry global market size, regional shares, competitors with a human chorionic gonadotropin market share, detailed human chorionic gonadotropin market segments, market trends, and opportunities, and any further data you may need to thrive in the human chorionic gonadotropin industry. This human chorionic gonadotropin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Human Chorionic Gonadotropin Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $1.03 billion
Revenue Forecast In 2034 $1.42 billion
Growth Rate CAGR of 8.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Technology: Natural Source Extraction, Recombinant Technology
2) By Therapeutic Area: Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End User: Fertility Clinics, Research Institutions, Other End Users Subsegments: 1) By Natural Source Extraction: Extraction From Pregnant Women's Urine, Extraction From Animal Sources
2) By Recombinant Technology: Recombinant Hcg, Recombinant Hcg For Therapeutic Use, Recombinant Hcg For Diagnostic Applications
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Merck & Co Inc., Novartis AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, Janssen Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Menarini Group, Cipla Limited, Hikma Pharmaceuticals plc, Ferring Pharmaceuticals Inc., Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Lupin Limited, Shenzhen Hepalink Pharmaceutical Group Co. Ltd., Scripps Laboratories Inc., Aspen Pharmacare Holdings Limited, Corona Remedies Pvt Ltd., Sanzyme Private Limited, Biocare Medical LLC, Lee BioSolutions Inc., MyBioSource Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Human Chorionic Gonadotropin Market Characteristics

    3. Human Chorionic Gonadotropin Market Trends And Strategies

    4. Human Chorionic Gonadotropin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Human Chorionic Gonadotropin Growth Analysis And Strategic Analysis Framework

    5.1. Global Human Chorionic Gonadotropin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Human Chorionic Gonadotropin Market Growth Rate Analysis

    5.4. Global Human Chorionic Gonadotropin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Human Chorionic Gonadotropin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Human Chorionic Gonadotropin Total Addressable Market (TAM)

    6. Human Chorionic Gonadotropin Market Segmentation

    6.1. Global Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Natural Source Extraction

    Recombinant Technology

    6.2. Global Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Female Infertility Treatment

    Oligospermic Treatment

    Male Hypogonadism

    Other Therapeutic Areas

    6.3. Global Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    6.4. Global Human Chorionic Gonadotropin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Fertility Clinics

    Research Institutions

    Other End Users

    6.5. Global Human Chorionic Gonadotropin Market, Sub-Segmentation Of Natural Source Extraction, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Extraction From Pregnant Women's Urine

    Extraction From Animal Sources

    6.6. Global Human Chorionic Gonadotropin Market, Sub-Segmentation Of Recombinant Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Recombinant Hcg

    Recombinant Hcg For Therapeutic Use

    Recombinant Hcg For Diagnostic Applications

    7. Human Chorionic Gonadotropin Market Regional And Country Analysis

    7.1. Global Human Chorionic Gonadotropin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Human Chorionic Gonadotropin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Human Chorionic Gonadotropin Market

    8.1. Asia-Pacific Human Chorionic Gonadotropin Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Human Chorionic Gonadotropin Market

    9.1. China Human Chorionic Gonadotropin Market Overview

    9.2. China Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Human Chorionic Gonadotropin Market

    10.1. India Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Human Chorionic Gonadotropin Market

    11.1. Japan Human Chorionic Gonadotropin Market Overview

    11.2. Japan Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Human Chorionic Gonadotropin Market

    12.1. Australia Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Human Chorionic Gonadotropin Market

    13.1. Indonesia Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Human Chorionic Gonadotropin Market

    14.1. South Korea Human Chorionic Gonadotropin Market Overview

    14.2. South Korea Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Human Chorionic Gonadotropin Market

    15.1. Western Europe Human Chorionic Gonadotropin Market Overview

    15.2. Western Europe Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Human Chorionic Gonadotropin Market

    16.1. UK Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Human Chorionic Gonadotropin Market

    17.1. Germany Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Human Chorionic Gonadotropin Market

    18.1. France Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Human Chorionic Gonadotropin Market

    19.1. Italy Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Human Chorionic Gonadotropin Market

    20.1. Spain Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Human Chorionic Gonadotropin Market

    21.1. Eastern Europe Human Chorionic Gonadotropin Market Overview

    21.2. Eastern Europe Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Human Chorionic Gonadotropin Market

    22.1. Russia Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Human Chorionic Gonadotropin Market

    23.1. North America Human Chorionic Gonadotropin Market Overview

    23.2. North America Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Human Chorionic Gonadotropin Market

    24.1. USA Human Chorionic Gonadotropin Market Overview

    24.2. USA Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Human Chorionic Gonadotropin Market

    25.1. Canada Human Chorionic Gonadotropin Market Overview

    25.2. Canada Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Human Chorionic Gonadotropin Market

    26.1. South America Human Chorionic Gonadotropin Market Overview

    26.2. South America Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Human Chorionic Gonadotropin Market

    27.1. Brazil Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Human Chorionic Gonadotropin Market

    28.1. Middle East Human Chorionic Gonadotropin Market Overview

    28.2. Middle East Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Human Chorionic Gonadotropin Market

    29.1. Africa Human Chorionic Gonadotropin Market Overview

    29.2. Africa Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Human Chorionic Gonadotropin Market Competitive Landscape And Company Profiles

    30.1. Human Chorionic Gonadotropin Market Competitive Landscape

    30.2. Human Chorionic Gonadotropin Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

    31. Human Chorionic Gonadotropin Market Other Major And Innovative Companies

    31.1. Janssen Pharmaceuticals Inc.

    31.2. Teva Pharmaceutical Industries Ltd.

    31.3. Sandoz International GmbH

    31.4. Sun Pharmaceutical Industries Limited

    31.5. Menarini Group

    31.6. Cipla Limited

    31.7. Hikma Pharmaceuticals plc

    31.8. Ferring Pharmaceuticals Inc.

    31.9. Intas Pharmaceuticals Ltd.

    31.10. Zydus Lifesciences Limited

    31.11. Lupin Limited

    31.12. Shenzhen Hepalink Pharmaceutical Group Co. Ltd.

    31.13. Scripps Laboratories Inc.

    31.14. Aspen Pharmacare Holdings Limited

    31.15. Corona Remedies Pvt Ltd.

    32. Global Human Chorionic Gonadotropin Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Human Chorionic Gonadotropin Market

    34. Recent Developments In The Human Chorionic Gonadotropin Market

    35. Human Chorionic Gonadotropin Market High Potential Countries, Segments and Strategies

    35.1 Human Chorionic Gonadotropin Market In 2029 - Countries Offering Most New Opportunities

    35.2 Human Chorionic Gonadotropin Market In 2029 - Segments Offering Most New Opportunities

    35.3 Human Chorionic Gonadotropin Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Human Chorionic Gonadotropin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Human Chorionic Gonadotropin Market, Sub-Segmentation Of Natural Source Extraction, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Human Chorionic Gonadotropin Market, Sub-Segmentation Of Recombinant Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Human Chorionic Gonadotropin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Human Chorionic Gonadotropin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: Merck & Co Inc. Financial Performance
  • Table 79: Novartis AG Financial Performance
  • Table 80: Bristol-Myers Squibb Company Financial Performance
  • Table 81: Fresenius Kabi AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Human Chorionic Gonadotropin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Human Chorionic Gonadotropin Market, Sub-Segmentation Of Natural Source Extraction, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Human Chorionic Gonadotropin Market, Sub-Segmentation Of Recombinant Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Human Chorionic Gonadotropin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Human Chorionic Gonadotropin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: Merck & Co Inc. Financial Performance
  • Figure 79: Novartis AG Financial Performance
  • Figure 80: Bristol-Myers Squibb Company Financial Performance
  • Figure 81: Fresenius Kabi AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Human Chorionic Gonadotropin market?

Human chorionic gonadotropin (hCG) is a hormone produced during pregnancy. It is produced by the placenta shortly after the embryo implants in the uterus. hCG plays a critical role in maintaining pregnancy by stimulating the corpus luteum (a structure in the ovary) to produce progesterone, which supports the uterine lining and prevents it from breaking down. For further insights on the Human Chorionic Gonadotropin market, request a sample here

How will the Human Chorionic Gonadotropin market drivers and restraints affect the market dynamics? What forces will shape the Human Chorionic Gonadotropin industry going forward?

The Human Chorionic Gonadotropin market major growth driver - Rising Infertility Rates to Fuel Growth In Human Chorionic Gonadotropin Market. For further insights on the Human Chorionic Gonadotropin market, request a sample here

What is the forecast market size or the forecast market value of the Human Chorionic Gonadotropin market?

The Human Chorionic Gonadotropin market size has grown strongly in recent years. The human chorionic gonadotropin market size has grown strongly in recent years. It will grow from $0.95 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the rise in the prevalence of hypogonadism in the geriatric population, increase in awareness toward HCG among healthcare professionals and patients, rise in popularity of fertility tourism, increase in the geriatric population, and increase in affordability and improvement in healthcare facilities. The human chorionic gonadotropin market size is expected to see strong growth in the next few years. It will grow to $1.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to the increasing incidence of infertility, surging prevalence of polycystic ovary syndrome, increasing female infertility, and rising usage of HCG in veterinary medicine. Major trends in the forecast period include advancements in pregnancy detection, innovative drug formulations, technological integration, focus on research and development, and product innovation. For further insights on the Human Chorionic Gonadotropin market, request a sample here

How is the Human Chorionic Gonadotropin market segmented?

The human chorionic gonadotropin market covered in this report is segmented –
1) By Technology: Natural Source Extraction, Recombinant Technology
2) By Therapeutic Area: Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End User: Fertility Clinics, Research Institutions, Other End Users
Subsegments:
1) By Natural Source Extraction: Extraction From Pregnant Women's Urine, Extraction From Animal Sources
2) By Recombinant Technology: Recombinant Hcg, Recombinant Hcg For Therapeutic Use, Recombinant Hcg For Diagnostic Applications For further insights on the Human Chorionic Gonadotropin market,
request a sample here

Which region has the largest share of the Human Chorionic Gonadotropin market? What are the other regions covered in the report?

North America was the largest region in the human chorionic gonadotropin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Human Chorionic Gonadotropin market, request a sample here.

Who are the major players in the Human Chorionic Gonadotropin market?

Major companies operating in the human chorionic gonadotropin market are focusing on developing innovative products, such as pregnancy detection kits, to improve diagnostic accuracy, enhance patient outcomes, and expand their market reach. Pregnancy detection kits are tools designed to confirm whether an individual is pregnant by detecting the presence of human chorionic gonadotropin (hCG) in their body. For instance, in June 2022, Proov, a US-based medical equipment manufacturing company, launched new hCG tests specifically designed for early pregnancy detection, enabling women to verify pregnancy up to six days before their expected period. These tests function by identifying the presence of human chorionic gonadotropin (hCG) in the urine. It offers high accuracy, with a reliability rate exceeding 99. This innovation seeks to provide women with a dependable and accessible method to monitor their pregnancy status earlier than traditional tests, empowering them to make informed decisions regarding their reproductive health.. For further insights on the Human Chorionic Gonadotropin market, request a sample here.

What are the key trends in the Human Chorionic Gonadotropin market?

Major trends in the Human Chorionic Gonadotropin market include hCG Test Kits Enhance Early Pregnancy Detection. For further insights on the Human Chorionic Gonadotropin market, request a sample here.

What are the major opportunities in the Human Chorionic Gonadotropin market? What are the strategies for the Human Chorionic Gonadotropin market?

For detailed insights on the major opportunities and strategies in the Human Chorionic Gonadotropin market, request a sample here.

How does the Human Chorionic Gonadotropin market relate to the overall economy and other similar markets?

For detailed insights on Human Chorionic Gonadotropin's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Human Chorionic Gonadotropin industry?

For detailed insights on the mergers and acquisitions in the Human Chorionic Gonadotropin industry, request a sample here.

What are the key dynamics influencing the Human Chorionic Gonadotropin market growth? SWOT analysis of the Human Chorionic Gonadotropin market.

For detailed insights on the key dynamics influencing the Human Chorionic Gonadotropin market growth and SWOT analysis of the Human Chorionic Gonadotropin industry, request a sample here.